A Case of Immunotherapy-Induced Balanitis

Terrence Sun1, Danielle Brazel1, Aditya Sarvaria1

  • 1Hematology and Medical Oncology, Scripps Clinic, San Diego, USA.

Cureus
|November 10, 2025
PubMed
Summary

Pembrolizumab immunotherapy can cause balanitis, a rare but serious skin reaction. This case report demonstrates successful treatment with topical agents, allowing continued cancer therapy and management of side effects.

Related Concept Videos